Dual Antiplatelet Therapy: Is It Time to Cut the Cord With Aspirin?
- PMID: 31237621
- DOI: 10.1001/jama.2019.7025
Dual Antiplatelet Therapy: Is It Time to Cut the Cord With Aspirin?
Comment on
-
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.
-
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.JAMA. 2019 Jun 25;321(24):2428-2437. doi: 10.1001/jama.2019.8146. JAMA. 2019. PMID: 31237645 Free PMC article. Clinical Trial.
Similar articles
-
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.Atherosclerosis. 2015 Sep;242(1):102-8. doi: 10.1016/j.atherosclerosis.2015.07.009. Epub 2015 Jul 11. Atherosclerosis. 2015. PMID: 26188531
-
Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.Thromb Haemost. 2015 Nov;114(5):1020-7. doi: 10.1160/TH15-03-0257. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26305340 Clinical Trial.
-
Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.Clin Appl Thromb Hemost. 2014 Oct;20(7):749-54. doi: 10.1177/1076029613481102. Epub 2013 Mar 14. Clin Appl Thromb Hemost. 2014. PMID: 23493759
-
Clopidogrel: the data, the experience, and the controversies.Am J Cardiovasc Drugs. 2012 Dec 1;12(6):361-74. doi: 10.2165/11636340-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 23057989 Review.
-
Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Ann Pharmacother. 2008. PMID: 18319394 Review.
Cited by
-
A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization.J Clin Med. 2022 Apr 8;11(8):2091. doi: 10.3390/jcm11082091. J Clin Med. 2022. PMID: 35456184 Free PMC article.
-
Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI.Am J Cardiovasc Drugs. 2021 Mar;21(2):153-163. doi: 10.1007/s40256-020-00430-0. Am J Cardiovasc Drugs. 2021. PMID: 32780215 Review.
-
Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint.J Thromb Thrombolysis. 2020 Jan;49(1):173-176. doi: 10.1007/s11239-019-01985-9. J Thromb Thrombolysis. 2020. PMID: 31686298
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
